Insights On Outsourced Drug Development

1. Studying The Spatial Architecture Of Glioblastoma 3/24/2025

   Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).

2. Automated Testing For Compound Toxicity Effects 3/17/2025

   Explore how anti-cancer drugs' toxic effects on intestinal cells limit dosages as well as how 3D organoids and assay automation can enhance drug development by improving testing processes.

3. Comprehensive Workflow For The Quantification Of Peptides And Proteins 7/29/2025

   Biologics are transforming medicine, with semaglutide leading the way. Discover how an automated LC-MS/MS workflow enables high-sensitivity quantification of peptides in plasma.

4. Analytical Tools To Address The Development Of GLP-1 Receptor Agonists 9/2/2025

   GLP-1 receptor agonists are revolutionizing therapeutics beyond diabetes. Explore analytical innovations that ensure safety and efficacy as these peptides expand into multiple treatments.

5. Versatile Lipid Nanoparticle Platform For Efficient Gene Editing 6/3/2025

   Lipid nanoparticles enable efficient gene editing in hard-to-transfect cells like T-cells and blood stem cells, which offers scalable, clinically relevant methods for developing advanced therapies for cancer and rare diseases.

6. Scalable Production Of High-Purity Nanobodies Using Yeast Expression System 9/8/2025

   Leverage scalable K. pastoris expression systems to produce high-quality nanobodies for cutting-edge therapeutic, diagnostic, and research applications.

7. Time To Intensify: Taking mAb Manufacturing To The Next Level 8/19/2025

   Explore how process intensification can revolutionize monoclonal antibody manufacturing to boost productivity, cut costs, and enhance sustainability with scalable strategies and real-world results.

8. Highly Sensitive ELISAs In 90 Minutes 9/11/2024

   Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.

9. Accelerating Drug Development: Flexible And Fast DNA-To-IND Programs 7/8/2024

   Gain expert insights on how tailored approaches and innovative technologies enable fast and flexible development workflows, ultimately supporting rapid therapeutic breakthroughs.

10. Enhancing mAb Processing With Protein A Membrane Chromatography For FIH Molecules 3/28/2025

    Our findings highlight this technology's potential in clinical development, providing greater flexibility, a smaller manufacturing footprint, and a more efficient purification process.